Graviton Bio Science announced it raised $39.8 Million in an initial filing from an offering of $50 Million
Graviton Bio Science announced it raised $39.8 Million in an initial filing from an offering of $50 Million
12/04/23, 8:11 PM
Location
new yorkMoney raised
$39.8 million
Industry
biotechnology
Company Info
Location
125 west end ave.
new york, new york, united states
Additional Info
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.